Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTKB | AMGN | BMY | VRTX | GILD |
| Company | Cytek Biosciences Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 5.68 | 277.67 | 56.50 | 462.80 | 87.63 |
| High | 6.14 | 281.60 | 58.65 | 463.90 | 88.60 |
| Low | 5.68 | 275.56 | 56.10 | 447.14 | 86.08 |
| Last | 6.13 | 279.95 | 58.23 | 448.01 | 87.75 |
| Change | +0.10 | +1.19 | +1.43 | -19.00 | -0.71 |
| % Change | +1.66% | +0.43% | +2.52% | -4.07% | -0.80% |
| Volume | 635,600 | 3,210,400 | 13,129,899 | 2,192,500 | 8,179,200 |
| 20-Day Average Volume | 918,365 | 2,649,900 | 12,111,150 | 1,271,110 | 7,665,045 |
| Previous Close | 6.03 | 278.76 | 56.80 | 467.01 | 88.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.84 | 310.06 | 55.42 | 481.25 | 90.77 |
| 20-Day Raw Stochastic | 49.49% | 8.33% | 69.26% | 1.20% | 13.03% |
| 20-Day Relative Strength | 54.57% | 27.93% | 61.09% | 39.88% | 48.98% |
| Weighted Alpha | -24.62 | -2.88 | +26.05 | +17.19 | +22.18 |
| Today's Opinion | 24% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 8% Buy | 40% Sell | 100% Buy | 32% Buy | 80% Buy |
| Last Month's Opinion | 100% Sell | 8% Buy | 72% Buy | 56% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.93% since 11/12/24 | -6.32% since 11/12/24 | -1.34% since 11/12/24 | -8.57% since 11/12/24 | -7.00% since 11/12/24 |
| Low | 5.68 on 11/19/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 447.14 on 11/19/24 | 86.08 on 11/19/24 |
| High | 7.15 on 11/13/24 | 307.43 on 11/13/24 | 59.73 on 11/14/24 | 498.25 on 11/13/24 | 94.21 on 11/13/24 |
| 1-Month | |||||
| %Chg | +18.57% since 10/18/24 | -12.97% since 10/18/24 | +9.41% since 10/18/24 | -7.24% since 10/18/24 | +1.19% since 10/18/24 |
| Low | 4.66 on 10/25/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 447.14 on 11/19/24 | 85.60 on 10/22/24 |
| High | 7.63 on 11/07/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +10.85% since 08/19/24 | -14.64% since 08/19/24 | +18.11% since 08/19/24 | -8.20% since 08/19/24 | +17.86% since 08/19/24 |
| Low | 4.66 on 10/25/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 447.14 on 11/19/24 | 74.34 on 08/20/24 |
| High | 7.63 on 11/07/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +0.49% since 05/17/24 | -10.41% since 05/17/24 | +32.25% since 05/17/24 | +0.63% since 05/17/24 | +29.58% since 05/17/24 |
| Low | 4.66 on 10/25/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 7.63 on 11/07/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 789,612 | 150,482,384 | 118,100,752 | 115,375,568 | 109,359,840 |
| Shares Outstanding, K | 128,811 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 193,020,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -12,150,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 51,500,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | 940,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.32 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 11/05/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/05/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.50 | 48.55 | 0.00 | 19.97 |